The American Journal of Medicine
Volume 120, Issue 5 , Pages 403-407 , May 2007

The Management of Sarcoidosis by the Primary Care Physician

  • Marc A. Judson, MD

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to Marc A. Judson, MD, Division of Pulmonary and Critical Care Medicine CSB-812, 96 Jonathan Lucas Street, Charleston, SC 29425.

References 

  1. Rybicki BA, Major M, Popovich Y, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol. 1997;145:234–241
  2. Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/WASOG statement on sarcoidosis. Sarcoid Vasc Diff Lung Dis. 1999;16:149–173
  3. Baughman RP, Teirstein AS, Judson MA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001;164:1885–1889
  4. Lynch JP, Kazerooni EA, Gay SE. Pulmonary sarcoidosis. Clin Chest Med. 1997;755–785
  5. Shorr AF, Helman DL, Davies DB, Nathan SD. Sarcoidosis, race, and short-term outcomes following lung transplantation. Chest. 2004;125:990–996
  6. Winterbauer RH, Hutchinson JF. Use of pulmonary function tests in the management of sarcoidosis. Chest. 1980;640–647
  7. Judson MA. An approach to the treatment of pulmonary sarcoidosis with corticosteroids: the six phases of treatment. Chest. 1999;115:1158–1165
  8. Ohara K, Judson MA, Baughman RP. Clinical aspects of ocular sarcoidosis. Eur Respir J Monogr. 2005;10:188–209
  9. Sharma OP. Renal sarcoidosis and hypercalcemia. Eur Respir J Monogr. 2005;10:220–232
  10. Schulte W, Kirstien D, Drent M, Costabel U. Cardiac involvement in sarcoidosis. Eur Respir J Monogr. 2005;10:130–149
  11. Yazaki Y, Osobe M, Hiroe M, et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol. 88:1006-1010.
  12. Uemura A, Morimoto S, Hiramitsu S, et al. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J. 1999;138:299–302
  13. Chapelon-Abric C, de Zuttere D, DuHaut P, et al. Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine. 2004;83:315–334
  14. Umetani K, Ishihara T, Sawanobori T, et al. Successfully treated complete atrioventricular block with corticosteroid in a patient with cardiac sarcoidosis: usefulness of Gallium-67 and thallium-201 scintigraphy. Intern Med. 2000;39:245–248
  15. Vignaux O, Dhote R, Duboe D, et al. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis. Chest. 2002;122:1895–1901
  16. Okumura W, Iwasaki T, Toyama T, et al. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med. 2004;45:1989–1998
  17. Mezaki T, Chinushi M, Washizuka T, et al. Discrepancy between inducibility of ventricular tachycardia and activity of cardiac sarcoidosis: requirement of defibrillator implantation for the inactive stage of cardiac sarcoidosis. Intern Med. 2001;40:731–735

PII: S0002-9343(06)01188-0

doi: 10.1016/j.amjmed.2006.07.047

The American Journal of Medicine
Volume 120, Issue 5 , Pages 403-407 , May 2007

Article Tools